Peptide InjectionsAI
Emerging evidence

Follistatin 315

Peptide therapy: benefits, side effects, cost and protocols

Follistatin 315 is a specific isoform of follistatin that is membrane-bound and acts primarily in a localized, autocrine/paracrine manner. It inhibits myostatin and activin locally in muscle tissue, making it of interest for targeted muscle growth applications.

ByChris Riley(CFA)|Updated

Sources: FDA / PubMed / ClinicalTrials.gov View

FDA status
Research Only Not currently approved for human use in the US. Available as a research compound. Not eligible for compounding.
Evidence
Emerging Evidence

How Follistatin 315 works

Binds activin and myostatin locally within muscle tissue due to heparin-binding domain, providing targeted inhibition rather than systemic effects.

Key studies

40 papers on PubMed / 22 human trials

  1. 01

    Dynamics of inhibin subunit and follistatin mRNA during development of normal and polycystic ovary syndrome follicles

  2. 02

    Fujiwara T, Sidis Y, Welt C et al

    J Clin Endocrinol Metab

  3. 03

    Inhibin subunit mRNA increases with follicle maturity; polycystic ovary syndrome shows reduced inhibin alpha subunit levels

  4. 04

    Activin B Induces Noncanonical SMAD1/5/8 Signaling via BMP Type I Receptors in Hepatocytes: Evidence for a Role in Hepcidin Induction by Inflammation in Male Mice

  5. 05

    Canali S, Core AB, Zumbrennen-Bullough KB et al

    Endocrinology / Animal

  6. 06

    Activin B stimulates hepcidin via SMAD1/5/8 signaling; follistatin-315 blunts hepcidin induction during inflammation

  7. 07

    An engineered human follistatin variant: insights into the pharmacokinetic and pharmocodynamic relationships of a novel molecule with broad therapeutic potential

  8. 08

    Datta-Mannan A, Yaden B, Krishnan V et al

    J Pharmacol Exp Ther / Phase 1

  9. 09

    Engineered follistatin-Fc fusion showed 100-fold improvement in half-life and robust dose-dependent effects in muscle atrophy models

  10. 10

    Increased activin bioavailability enhances hepatic insulin sensitivity while inducing hepatic steatosis in male mice

Follistatin 315 questions

What is FOLLISTATIN 315?

Follistatin 315 is a tissue-bound isoform of follistatin with more localized myostatin-blocking activity compared to the circulating Follistatin 344 variant.

How does FOLLISTATIN 315 work?

Binds activin and myostatin locally within muscle tissue due to heparin-binding domain, providing targeted inhibition rather than systemic effects.

Is FOLLISTATIN 315 legal to buy?

FOLLISTATIN 315 is sold as a research chemical for laboratory use only. It is not approved for human use by the FDA. Regulations vary by jurisdiction.

Where can I buy FOLLISTATIN 315?

FOLLISTATIN 315 is available as a research compound from verified online vendors. Always verify third-party testing before purchasing.

What category does FOLLISTATIN 315 belong to?

FOLLISTATIN 315 is primarily classified as a growth hormone secretion peptide. Peptides that stimulate or support growth hormone release, including GHRH analogs, GHRPs, and direct GH compounds for muscle, recovery, and anti-aging research.

What are the research benefits of FOLLISTATIN 315?

FOLLISTATIN 315 has been studied for: Localized myostatin inhibition, Targeted muscle support, Lean mass preservation. Tissue-bound follistatin isoform; more targeted than FS-344.

Follistatin 315 in the news

News aggregated via Google News. Inclusion does not imply endorsement.

Considering Follistatin 315?

The 2-minute quiz matches you with licensed providers who offer it. A clinician decides if it fits.

Take the quiz